Hamilton Lane Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$15.6M |
| 2 |
Amalgamated Financial
AMAL
|
+$8.83M |
| 3 |
Expensify
EXFY
|
+$5.11M |
| 4 |
QuantumScape Corp
QS
|
+$3.71M |
| 5 |
Remitly
RELY
|
+$2.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
On Holding
ONON
|
+$4.23M |
| 2 |
Airbnb
ABNB
|
+$3.77M |
| 3 |
TELA Bio
TELA
|
+$1.85M |
| 4 |
Procore
PCOR
|
+$983K |
| 5 |
DCT
Duck Creek Technologies, Inc. Common Stock
DCT
|
+$869K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.95% |
| 2 | Financials | 31.01% |
| 3 | Consumer Discretionary | 10.03% |
| 4 | Healthcare | 9.25% |
| 5 | Industrials | 3.04% |
Similar funds
Hamilton Lane Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Hamilton Lane Advisors held 78 positions worth $273M, up 5.8% from $258M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Hamilton Lane Advisors deployed $23.4M of net new capital in Q3 2022, opening 8 new positions and adding to 8 existing holdings. Its largest new stake was Karuna Therapeutics, Inc. Common Stock: 77,286 shares worth $17.4M.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 42% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Airbnb, an estimated $3.77M trimmed.
- Hamilton Lane Advisors's largest Q3 2022 buy was Karuna Therapeutics, Inc. Common Stock: 77,286 shares worth $17.4M.
- Hamilton Lane Advisors added most to QuantumScape Corp in Q3 2022, an estimated $3.71M increase.
- Hamilton Lane Advisors's biggest Q3 2022 reduction was Airbnb, cutting an estimated $3.77M.
- Hamilton Lane Advisors fully exited On Holding in Q3 2022, selling an estimated $4.23M.
- Hamilton Lane Advisors's ten largest holdings make up 76% of its $273M portfolio in Q3 2022.
- Hamilton Lane Advisors opened 8 new positions and closed 12 in Q3 2022.
- Hamilton Lane Advisors's portfolio value rose 5.8% quarter-over-quarter to $273M.
Based on Hamilton Lane Advisors's 13F filing for Q3 2022, filed 8 Nov 2022.